{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:08:51Z","timestamp":1781536131572,"version":"3.54.5"},"reference-count":111,"publisher":"SAGE Publications","issue":"10","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:p>Montelukast, a Food and Drug Administration-approved drug for asthma and allergic rhinitis modulates leukotriene (LT) receptors and serves as a critical anti-inflammatory agent. Recent research suggests that the LT signaling pathway targeted by montelukast has broader implications for diseases such as fibrosis, cardiovascular diseases, cancer, cerebrovascular disease, and immune defense. This expanded understanding highlights montelukast\u2019s potential for repurposing in conditions involving aberrant stress mechanisms, including ocular diseases marked by inflammation, oxidative stress, ER stress, and apoptosis, among several others. This review delves into montelukast\u2019s therapeutic mechanisms across various diseases, draws parallels to ocular conditions, and examines clinical trials and associated adverse effects to underscore the unmet need for cysteinyl LT receptor antagonism by montelukast as an effective therapy for visual deficits.<\/jats:p>","DOI":"10.1089\/jop.2024.0111","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T23:05:22Z","timestamp":1727910322000},"page":"617-628","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Cysteinyl Leukotriene Receptor Antagonism by Montelukast to Treat Visual Deficits"],"prefix":"10.1177","volume":"40","author":[{"given":"Amritha T.M.","family":"Seetharaman","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline E.","family":"Owens","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, Tennessee, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6664-8286","authenticated-orcid":false,"given":"Rajashekhar","family":"Gangaraju","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Anatomy &amp; Neurobiology, Neuroscience Institute, University of Tennessee Health Science Center, Memphis, Tennessee, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci97946"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-394300-2.00002-8"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13308"},{"issue":"2","key":"e_1_3_5_5_2","first-page":"2387","article-title":"Montelukast inhibits RANKL-induced osteoclast formation and bone loss via CysLTR1 and P2Y12","volume":"18","author":"Kang JH","year":"2018","unstructured":"Kang JH, , Lim H, , Lee DS, et al. Montelukast inhibits RANKL-induced osteoclast formation and bone loss via CysLTR1 and P2Y12. Mol Med Rep, 2018; 18(2):2387\u20132398.","journal-title":"Mol Med Rep"},{"key":"e_1_3_5_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1984003"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M101103200"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i4.968"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004350"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(03)00187-6"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10112"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203787"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2023.109517"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2020.158756"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxz044"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108806"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0026"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74755-w"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001651"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/398076"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23208"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.3389\/fopht.2022.756689"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-021-01484-3"},{"issue":"8","key":"e_1_3_5_24_2","first-page":"167","article-title":"Evaluation of regression of diabetes-induced nephropathy and vascular dysfunction in rats by Montelukast via antioxidative and anti-inflammatory actions","volume":"13","author":"Anbar HS","year":"2023","unstructured":"Anbar HS, , Shehatou GS, , Abdel-Rahim M, et al. Evaluation of regression of diabetes-induced nephropathy and vascular dysfunction in rats by Montelukast via antioxidative and anti-inflammatory actions. J Appl Pharm Sci, 2023; 13(8):167\u2013176.","journal-title":"J Appl Pharm Sci"},{"issue":"14","key":"e_1_3_5_25_2","first-page":"2214","article-title":"Leukotriene receptor antagonism reduces early diabetic retinopathy in the mouse","volume":"53","author":"Gubitosi-Klug RA","year":"2012","unstructured":"Gubitosi-Klug RA, , Talahalli R. Leukotriene receptor antagonism reduces early diabetic retinopathy in the mouse. Investigative Ophthalmology & Visual Science, 2012; 53(14):2214\u20132214.","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"9","key":"e_1_3_5_26_2","first-page":"190","article-title":"Montelukast modulates the NF-kB inflammatory cascade in mouse retinal endothelial cells","volume":"59","author":"Bapputty RM","year":"2018","unstructured":"Bapputty RM, , Talahalli R, , Gubitosi-Klug RA. Montelukast modulates the NF-kB inflammatory cascade in mouse retinal endothelial cells. Investigative Ophthalmology & Visual Science, 2018; 59(9):190\u2013190.","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"8","key":"e_1_3_5_27_2","first-page":"5219","article-title":"Montelukast modulates diabetes-induced inflammation and electrophysiological changes in early diabetic retinopathy in the mouse","volume":"58","author":"Bapputty R","year":"2017","unstructured":"Bapputty R, , Samuels IS, , Talahalli R, et al. Montelukast modulates diabetes-induced inflammation and electrophysiological changes in early diabetic retinopathy in the mouse. Investigative Ophthalmology & Visual Science, 2017; 58(8):5219\u20135219.","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e318177ebac"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2012.03.010"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7836828"},{"key":"e_1_3_5_31_2","first-page":"922","article-title":"Classification of oxidative stress based on its intensity","volume":"13","author":"Lushchak VI","year":"2014","unstructured":"Lushchak VI. Classification of oxidative stress based on its intensity. Excli J, 2014; 13:922\u2013937.","journal-title":"Excli J"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9080761"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00233-1"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-061516-045037"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2001-0039"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031255"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/0748233713505894"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22231"},{"issue":"3","key":"e_1_3_5_39_2","first-page":"211","article-title":"Protective effects of Montelukast against stress-induced degeneration of the urinary bladder","volume":"8","author":"D\u00fclger E\u00c7","year":"2018","unstructured":"D\u00fclger E\u00c7, , \u00c7anillio\u011flu YE, , \u00c7etinel \u015e, et al. Protective effects of Montelukast against stress-induced degeneration of the urinary bladder. Clinical and Experimental Health Sciences, 2018; 8(3):211\u2013216.","journal-title":"Clinical and Experimental Health Sciences"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9396425"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2008.01.007"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01570-w"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4001"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59237-3"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2199"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1209038"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201110131"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)00108-8"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1146361"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012513-104649"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2017.06.006"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e25937"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27072"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612825666190115122622"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47246-w"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2051689"},{"key":"e_1_3_5_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120865"},{"key":"e_1_3_5_58_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7301.1536"},{"key":"e_1_3_5_59_2","doi-asserted-by":"publisher","DOI":"10.1080\/01926230701320337"},{"key":"e_1_3_5_60_2","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20180992"},{"key":"e_1_3_5_61_2","doi-asserted-by":"publisher","DOI":"10.15171\/apb.2019.024"},{"key":"e_1_3_5_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2016.09.022"},{"key":"e_1_3_5_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2014.01.011"},{"key":"e_1_3_5_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707577"},{"key":"e_1_3_5_65_2","doi-asserted-by":"publisher","DOI":"10.3109\/13816819609057889"},{"key":"e_1_3_5_66_2","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9570.1000298"},{"key":"e_1_3_5_67_2","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2024.13207"},{"key":"e_1_3_5_68_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083903"},{"key":"e_1_3_5_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-024-01977-y"},{"key":"e_1_3_5_70_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413384"},{"key":"e_1_3_5_71_2","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2019.1687502"},{"key":"e_1_3_5_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2010.08.039"},{"key":"e_1_3_5_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2012.07.015"},{"key":"e_1_3_5_74_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.3.22"},{"key":"e_1_3_5_75_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-06523-2"},{"key":"e_1_3_5_76_2","volume-title":"The Endothelium: Part 1: Multiple Functions of the Endothelial Cells\u2014Focus on Endothelium-Derived Vasoactive Mediators","author":"F\u00e9l\u00e9tou M","year":"2011","unstructured":"F\u00e9l\u00e9tou M. Integrated Systems Physiology: from Molecule to Function to Disease. In: The Endothelium: Part 1: Multiple Functions of the Endothelial Cells\u2014Focus on Endothelium-Derived Vasoactive Mediators. Morgan & Claypool Life Sciences Copyright \u00a9 2011 by Morgan & Claypool Life Sciences Publishers.: San Rafael (CA); 2011."},{"key":"e_1_3_5_77_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.Asn.0000132474.50966.Da"},{"key":"e_1_3_5_78_2","doi-asserted-by":"publisher","DOI":"10.5339\/gcsp.2014.43"},{"key":"e_1_3_5_79_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01568"},{"key":"e_1_3_5_80_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-018-0042-6"},{"key":"e_1_3_5_81_2","doi-asserted-by":"publisher","DOI":"10.2174\/0115734021276985231204092425"},{"key":"e_1_3_5_82_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-019-00611-7"},{"key":"e_1_3_5_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.02.125"},{"key":"e_1_3_5_84_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00591"},{"key":"e_1_3_5_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100904"},{"key":"e_1_3_5_86_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2007.01167.x"},{"key":"e_1_3_5_87_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2013.5371"},{"key":"e_1_3_5_88_2","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2011.152"},{"key":"e_1_3_5_89_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00836-3"},{"key":"e_1_3_5_90_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-023-01301-1"},{"key":"e_1_3_5_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119507"},{"key":"e_1_3_5_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.114931"},{"key":"e_1_3_5_93_2","doi-asserted-by":"publisher","DOI":"10.3390\/life11030189"},{"key":"e_1_3_5_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110959"},{"key":"e_1_3_5_95_2","doi-asserted-by":"publisher","DOI":"10.1097\/ms9.0000000000002085"},{"issue":"8","key":"e_1_3_5_96_2","first-page":"1152","article-title":"Oral montelukast is associated with decreased odds of diabetic retinopathy","volume":"62","author":"Pham B","year":"2021","unstructured":"Pham B, , Matsumiya W, , Akhavanrezayat A, et al. Oral montelukast is associated with decreased odds of diabetic retinopathy. Investigative Ophthalmology & Visual Science, 2021; 62(8):1152\u20131152.","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"e_1_3_5_97_2","doi-asserted-by":"publisher","DOI":"10.1159\/000366164"},{"key":"e_1_3_5_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.12.070"},{"key":"e_1_3_5_99_2","volume-title":"StatPearls. StatPearls Publishing. Copyright \u00a9 2024","author":"Choi J","year":"2024","unstructured":"Choi J, , Azmat CE. Leukotriene Receptor Antagonists. In: StatPearls. StatPearls Publishing. Copyright \u00a9 2024, StatPearls Publishing LLC: Treasure Island (FL); 2024."},{"key":"e_1_3_5_100_2","volume-title":"StatPearls. StatPearls Publishing. Copyright \u00a9 2024","author":"Wermuth HR","year":"2024","unstructured":"Wermuth HR, , Badri T, , Takov V. Montelukast. In: StatPearls. StatPearls Publishing. Copyright \u00a9 2024, StatPearls Publishing LLC: Treasure Island (FL); 2024."},{"key":"e_1_3_5_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.02.057"},{"key":"e_1_3_5_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2006.10.002"},{"key":"e_1_3_5_103_2","doi-asserted-by":"publisher","DOI":"10.4103\/0022-3859.52850"},{"key":"e_1_3_5_104_2","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2007.462"},{"key":"e_1_3_5_105_2","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.02298"},{"key":"e_1_3_5_106_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2003.01266.x"},{"key":"e_1_3_5_107_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2008.02737.x"},{"key":"e_1_3_5_108_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D547"},{"key":"e_1_3_5_109_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080408"},{"key":"e_1_3_5_110_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121056"},{"key":"e_1_3_5_111_2","unstructured":"FDA requires stronger warning about risk of neuropsychiatric events associated with asthma and allergy medication singulair and generic Montelukast. Available from:https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-requires-stronger-warning-about-risk-neuropsychiatric-events-associated-asthma-and-allergy [Last accessed: June3 2024]."},{"key":"e_1_3_5_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-2952(02)00889-4"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jop.2024.0111","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2024.0111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2024.0111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:46:39Z","timestamp":1777646799000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jop.2024.0111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":111,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,12,1]]}},"alternative-id":["10.1089\/jop.2024.0111"],"URL":"https:\/\/doi.org\/10.1089\/jop.2024.0111","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}